{{About|a non-clinically used progestin compound|the pharmaceutical drug|nomegestrol acetate}}
{{Drugbox
| IUPAC_name = (17α)-17-acetyl-17-hydroxy-6-methylestra-4,6-dien-3-one
| image = Nomegestrol.svg
| CAS_number = 58691-88-6
| CAS_supplemental = 
| ATC_prefix = G03
| ATC_suffix = DB04
| PubChem = 68783
| ChemSpiderID = 62024
| KEGG = D07222
| C=21 | H=28 | O=3
| molecular_weight = 328.445 g/mol
| smiles = O=C4\C=C3\C(=C/[C@@H]1[C@H](CC[C@@]2([C@@](O)(C(=O)C)CC[C@@H]12)C)[C@H]3CC4)C
| StdInChI = 1S/C21H28O3/c1-12-10-18-16(15-5-4-14(23)11-17(12)15)6-8-20(3)19(18)7-9-21(20,24)13(2)22/h10-11,15-16,18-19,24H,4-9H2,1-3H3/t15-,16-,18-,19+,20+,21+/m1/s1
| StdInChIKey = KZUIYQJTUIACIG-YBZCJVABSA-N
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 
}}

'''Nomegestrol''' ([[International Nonproprietary Name|INN]]), also known as '''19-normegestrol''', is a [[steroid]]al [[progestin]] which was patented in 1975 but was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA883|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=883–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA747|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=747–}}</ref> It is the parent compound of [[nomegestrol acetate]], which is marketed as a progestin.<ref name="Elks2014" /><ref name="IndexNominum2000" />

==See also==
* [[Medroxyprogesterone]]
* [[Megestrol]]

==References==
{{reflist}}

{{Progesterone receptor modulators}}
{{Androgen receptor modulators}}

[[Category:Antiandrogens]]
[[Category:Norpregnanes]]
[[Category:Progestogens]]
[[Category:Abandoned drugs]]

{{steroid-stub}}
{{genito-urinary-drug-stub}}